Background and purpose We systematically reviewed available evidence for reports of
neurological signs and symptoms in patients with COVID‐19 to identify cases with severe …

Background and purpose Infections with coronaviruses are not always confined to the
respiratory tract and various neurological manifestations have been reported. The aim of this …

Introduction The past two decades have been marked by three epidemics linked to
emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological …

Object The novel severe acute respiratory syndrome (SARS)-CoV-2 outbreak has been
declared a pandemic in March, 2020. An increasing body of evidence suggests that patients …

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),
was first identified in December of 2019 in the city of Wuhan, China. Since the outbreak …

Abstract Background Coronavirus disease 2019 (COVID-19) has become a global
pandemic, affecting millions of people. However, clinical research on its neurological …

Objective To study the frequency of neurological symptoms and complications in COVID-19
patients in a systematic review of the literature. Methods Relevant studies were identified …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China and rapidly spread worldwide, with a vast majority of confirmed cases …

Acute and post-acute neurological symptoms, signs and diagnoses have been documented
in an increasing number of patients infected by the Severe Acute Respiratory Syndrome …

Background Increasing research reports neurological manifestations of COVID-19 patients.
SARS-CoV-2 shares homology with other human coronaviruses that have also had nervous …